Medlive Technology (02192) Announces January 2026 Monthly Return

Bulletin Express

Feb 05

Medlive Technology Co., Ltd. (stock code: 02192) released its January 2026 monthly return on equity securities, which showed no changes in the authorized share capital. The total authorized/registered capital remained at USD 500,000, corresponding to 50,000,000,000 ordinary shares with a par value of USD 0.00001 each.

During January 2026, the total number of issued ordinary shares increased from 737,030,875 to 737,960,875. This rise of 930,000 shares resulted from the exercise of options under the Pre-IPO Share Option Scheme at an exercise price of RMB 0.38 per share, generating RMB 353,400 of funds.

The company confirmed that the public float requirement stands at 24.98% of the total issued shares for this class, and the requirement was satisfied as of the end of January 2026. No additional equity-related instruments, such as warrants or convertibles, were reported.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1196249974"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1196249974\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1196249974?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-05 16:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1196249974","market":"hk","top_or_hot":-1,"title":"Medlive Technology (02192) Announces January 2026 Monthly Return","media":"Bulletin Express","content":"<p>Medlive Technology Co., Ltd. (stock code: 02192) released its January 2026 monthly return on equity securities, which showed no changes in the authorized share capital. The total authorized/registered capital remained at USD 500,000, corresponding to 50,000,000,000 ordinary shares with a par value of USD 0.00001 each.</p>\n<p>During January 2026, the total number of issued ordinary shares increased from 737,030,875 to 737,960,875. This rise of 930,000 shares resulted from the exercise of options under the Pre-IPO Share Option Scheme at an exercise price of RMB 0.38 per share, generating RMB 353,400 of funds.</p>\n<p>The company confirmed that the public float requirement stands at 24.98% of the total issued shares for this class, and the requirement was satisfied as of the end of January 2026. No additional equity-related instruments, such as warrants or convertibles, were reported.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Medlive Technology (02192) Announces January 2026 Monthly Return</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMedlive Technology (02192) Announces January 2026 Monthly Return\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-05 16:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Medlive Technology Co., Ltd. (stock code: 02192) released its January 2026 monthly return on equity securities, which showed no changes in the authorized share capital. The total authorized/registered capital remained at USD 500,000, corresponding to 50,000,000,000 ordinary shares with a par value of USD 0.00001 each.</p>\n<p>During January 2026, the total number of issued ordinary shares increased from 737,030,875 to 737,960,875. This rise of 930,000 shares resulted from the exercise of options under the Pre-IPO Share Option Scheme at an exercise price of RMB 0.38 per share, generating RMB 353,400 of funds.</p>\n<p>The company confirmed that the public float requirement stands at 24.98% of the total issued shares for this class, and the requirement was satisfied as of the end of January 2026. No additional equity-related instruments, such as warrants or convertibles, were reported.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02192","symbol_name":"医脉通","start_time":0,"source_url":"","article_id":"1196249974","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196249974","pubTimestamp":1770281945,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Medlive Technology Co., Ltd. (stock code: 02192) released its January 2026 monthly return on equity securities, which showed no changes in the authorized share capital. The total...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02192":"医脉通"},"translate_title":"Medlive Technology(02192)公布2026年1月月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02192":1},"content_text":"Medlive Technology Co., Ltd. (stock code: 02192) released its January 2026 monthly return on equity securities, which showed no changes in the authorized share capital. The total authorized/registered capital remained at USD 500,000, corresponding to 50,000,000,000 ordinary shares with a par value of USD 0.00001 each.\nDuring January 2026, the total number of issued ordinary shares increased from 737,030,875 to 737,960,875. This rise of 930,000 shares resulted from the exercise of options under the Pre-IPO Share Option Scheme at an exercise price of RMB 0.38 per share, generating RMB 353,400 of funds.\nThe company confirmed that the public float requirement stands at 24.98% of the total issued shares for this class, and the requirement was satisfied as of the end of January 2026. No additional equity-related instruments, such as warrants or convertibles, were reported.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}